about
sameAs
Human p300 protein is a coactivator for the transcription factor MyoDWhen chocolate seeking becomes compulsion: gene-environment interplayHistone Modifications in a Mouse Model of Early Adversities and Panic Disorder: Role for Asic1 and Neurodevelopmental Genes.The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cellsReciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblastsLMNA knock-down affects differentiation and progression of human neuroblastoma cellsEarly handling and repeated cross-fostering have opposite effect on mouse emotionalityMyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway.MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection.Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.Defining new criteria for selection of cell-based intestinal models using publicly available databases.PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family membersSignaling by exosomal microRNAs in cancer.Expression in male and genomic organization of the gene(s) coding for a major protein secreted by the rat seminal vesicle epithelium.Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomasBrahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesisThe transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins.New technologies used in the study of human melanoma.Identification of pivotal cellular factors involved in HPV-induced dysplastic and neoplastic cervical pathologies.MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.The role of CDX2 in Caco-2 cell differentiation.Differentiation of Caco-2 cells requires both transcriptional and post-translational down-regulation of Myc.Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer.Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.Identification of genes down-regulated during melanoma progression: a cDNA array study.Interaction between the pRb2/p130 C-terminal domain and the N-terminal portion of cyclin D3.pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation.Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways.Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells.Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer.Contribution of serine racemase/d-serine pathway to neuronal apoptosis.Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.Impact of different ChIP-Seq protocols on DNA integrity and quality of bioinformatics analysis results.
P50
Q24336865-958606D3-AFD3-4209-B991-96571F127189Q27311537-9BEE8CA1-A8ED-4B64-A4B6-966123CDE366Q27318328-955B36F4-10DB-46FD-A98D-4EB80EB12EEFQ28202860-C042F846-E936-4A8C-8579-FEE8DAAADB55Q28204258-DABE8627-A207-45E5-8F8A-F463A4CC047CQ28484053-9433283D-2351-48B3-BC3E-95F2243C122AQ30412450-276DA740-1EEF-4E1A-81FA-68F6735ED124Q33289358-BBACB767-095F-48E3-9B0C-B5840D06D443Q33440553-65D3A402-9C15-4840-841F-572EFD44A258Q33820633-2E5CF06A-E20C-44C6-83ED-72B0D2028908Q34142769-6E5FA517-E2FA-4FE5-9A8D-5DD502A0747BQ34314896-75ED447E-030F-44DA-B69F-CE77C07F7677Q34535041-D50BA298-1578-46FD-8FEB-90454C62D393Q34894993-3BB5A554-0731-4D48-9B07-DE690B86F894Q35344075-0817538F-2324-40A3-9667-7C3F9851662AQ35488422-481F4719-C074-4933-A562-162231321EB3Q35771966-7CF970E3-2566-4D8C-ABBC-8102EFD1CAB8Q36004275-C4529F99-AAE9-4AED-9351-4338344FF8E2Q36356011-4AA3BFBB-9D61-4A7E-AC04-957238FF7CD5Q36544990-BDFD2FAC-E762-401C-9729-4D7192DD0283Q36579274-4A6E7625-EF7C-4093-9E94-2080D5194BA3Q36845724-F91C75AB-68AC-4765-B904-80AF5BD6DF10Q38394648-6DE2F1F4-B424-4AA0-9ED8-6ED331FD0E7BQ39022048-651F8993-C2C7-47E0-A3FD-5DC05337716AQ39108303-98114910-8E6E-492B-A661-2B5B228B611BQ39390441-70E874DC-146E-41E1-84A8-63829B9F3642Q39644382-585BD954-3FA7-47BB-A4DB-17FD0E3A870FQ39728359-BB1A1D6A-9896-4ED9-AD62-0B7568E0BD50Q40228065-EB41ECD1-B477-45AD-8727-14FD56CA4231Q40438002-E3EE204C-6101-4034-8D03-F5C5729140D4Q40511673-5727CA4D-E1FC-442B-B3A0-87924AB7CF12Q40654290-4BFBA25D-484A-4E67-930E-EDAC2A1E86F6Q40916266-B2C88FEB-0396-4F22-A36A-A799C0C223AFQ41808370-87DE249B-ECA4-4D16-831B-4E1BAAE0D4B9Q43078670-D4FF618B-150A-4A96-86ED-63DC5D9BA864Q45961792-D9ECDBAE-CDD6-4C56-A2DF-B6C1718120A5Q46781616-636E0CCE-889F-42AA-BFCA-F62F63EB74C4Q47899065-2A90EC2C-6006-41AF-935A-29A6EC8CE75FQ48521953-502D2996-65DC-4579-BE24-9EE52303E5DBQ51109287-F9E7C358-0723-444C-9562-FEB428C21352
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Armando Felsani
@ast
Armando Felsani
@en
Armando Felsani
@es
Armando Felsani
@nl
Armando Felsani
@sl
type
label
Armando Felsani
@ast
Armando Felsani
@en
Armando Felsani
@es
Armando Felsani
@nl
Armando Felsani
@sl
prefLabel
Armando Felsani
@ast
Armando Felsani
@en
Armando Felsani
@es
Armando Felsani
@nl
Armando Felsani
@sl
P1053
D-1784-2010
P106
P1153
7003280502
P21
P31
P3829
P496
0000-0001-8851-6295